Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 4/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7330167 | 1.00 | ACE (0.77) | ACE | |
| SCHEMBL7324072 | 0.99 | ACE (0.78) | ACE | |
| SCHEMBL682298 | 0.99 | ACE (0.78) | ACE | |
| SCHEMBL11272339 | 0.93 | ACE (0.71) | ACE | |
| SCHEMBL7327307 | 0.92 | ACE (0.70) | ACE | |
| SCHEMBL30999001 | 0.90 | ACE (0.71) | ACE | |
| SCHEMBL7197807 | 0.90 | ACE (0.64) | ACE | |
| SCHEMBL7320652 | 0.90 | ACE (0.64) | ACE | |
| SCHEMBL7325543 | 0.90 | ACE (0.64) | ACE | |
| SCHEMBL2230723 | 0.90 | ACE (0.64) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0279750-B1 | AMINOACID DERIVATIVES AS ANTIHYPERTENSIVES | Asahi Breweries, Ltd. (JP) | 1993-01-20 | — | — | EP | claimed |
| US-4897483-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | ASAHI BREWERIES LTD. (JP) | 1990-01-30 | — | — | US | claimed |
| EP-0279750-A2 | Aminoacid derivatives as antihypertensives | Asahi Breweries, Ltd. (JP) | 1988-08-24 | — | — | EP | claimed |
| EP-0279750-B1 | AMINOACID DERIVATIVES AS ANTIHYPERTENSIVES | Asahi Breweries, Ltd. (JP) | 1993-01-20 | — | — | EP | disclosed |
| EP-0279750-A2 | Aminoacid derivatives as antihypertensives | Asahi Breweries, Ltd. (JP) | 1988-08-24 | — | — | EP | disclosed |